Cargando…

Pharmacy practice in emergency response during the COVID-19 pandemic: Lessons from Australia

The purpose of this paper is to provide an overview of the pharmacy practice and initiatives taken by the Australian federal government to ensure the continued supply of essential medicines under the conditions of an emergency response plan for COVID-19. During the pandemic, Australian pharmacists h...

Descripción completa

Detalles Bibliográficos
Autores principales: Parajuli, Daya Ram, Khanal, Saval, Wechkunanukul, Kannikar Hannah, Ghimire, Saurav, Poudel, Arjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404372/
https://www.ncbi.nlm.nih.gov/pubmed/34810136
http://dx.doi.org/10.1016/j.sapharm.2021.08.013
_version_ 1783746155301044224
author Parajuli, Daya Ram
Khanal, Saval
Wechkunanukul, Kannikar Hannah
Ghimire, Saurav
Poudel, Arjun
author_facet Parajuli, Daya Ram
Khanal, Saval
Wechkunanukul, Kannikar Hannah
Ghimire, Saurav
Poudel, Arjun
author_sort Parajuli, Daya Ram
collection PubMed
description The purpose of this paper is to provide an overview of the pharmacy practice and initiatives taken by the Australian federal government to ensure the continued supply of essential medicines under the conditions of an emergency response plan for COVID-19. During the pandemic, Australian pharmacists have been working collaboratively with multidisciplinary teams at the frontline to manage the equitable and safe supply of medicines despite the unprecedented situation. Although these presented problems for small pharmacies, social distancing policies were implemented widely to maintain personal and environmental hygiene and reduce the number of face-to-face patient visits. In collaboration with various pharmaceutical stakeholders, the Australian government responded rapidly to ensure equitable and sufficient supply with continued access to therapeutic goods during the pandemic. Additionally, vital policies and practices have been implemented, including supplying regular medicines at government-subsidized prices, a maximum one-month supply of some prescription medicines and purchase limits on over-the-counter medicines (one unit per purchase), medication management reviews through telehealth, electronic and digital prescribing, home delivery of medicines to vulnerable people and those in home isolation and the provision of serious shortage medicine substitution rights to pharmacists. Pharmacists were encouraged to communicate and collaborate with other local pharmacies to ensure that essential pharmacy services met community needs (e.g., opening hours). However, there has been a shortage of some medicines due to supply chain disruption and increased demand due to the pandemic. Higher demand for flu vaccinations, increased work pressure in pharmacies, and severe frustration and anxiety in pharmacy customers were also reported. Vigilance is required to monitor foreseeable shortages of therapeutics goods, particularly in regional pharmacies. There is an opportunity for long-term change to retain certain rights and roles based on the competence shown by pharmacists in this challenging period, such as telephone medication reviews, telehealth for MedsCheck and Diabetes MedsCheck, digital prescription handling and therapeutic substitution.
format Online
Article
Text
id pubmed-8404372
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-84043722021-08-30 Pharmacy practice in emergency response during the COVID-19 pandemic: Lessons from Australia Parajuli, Daya Ram Khanal, Saval Wechkunanukul, Kannikar Hannah Ghimire, Saurav Poudel, Arjun Res Social Adm Pharm Article The purpose of this paper is to provide an overview of the pharmacy practice and initiatives taken by the Australian federal government to ensure the continued supply of essential medicines under the conditions of an emergency response plan for COVID-19. During the pandemic, Australian pharmacists have been working collaboratively with multidisciplinary teams at the frontline to manage the equitable and safe supply of medicines despite the unprecedented situation. Although these presented problems for small pharmacies, social distancing policies were implemented widely to maintain personal and environmental hygiene and reduce the number of face-to-face patient visits. In collaboration with various pharmaceutical stakeholders, the Australian government responded rapidly to ensure equitable and sufficient supply with continued access to therapeutic goods during the pandemic. Additionally, vital policies and practices have been implemented, including supplying regular medicines at government-subsidized prices, a maximum one-month supply of some prescription medicines and purchase limits on over-the-counter medicines (one unit per purchase), medication management reviews through telehealth, electronic and digital prescribing, home delivery of medicines to vulnerable people and those in home isolation and the provision of serious shortage medicine substitution rights to pharmacists. Pharmacists were encouraged to communicate and collaborate with other local pharmacies to ensure that essential pharmacy services met community needs (e.g., opening hours). However, there has been a shortage of some medicines due to supply chain disruption and increased demand due to the pandemic. Higher demand for flu vaccinations, increased work pressure in pharmacies, and severe frustration and anxiety in pharmacy customers were also reported. Vigilance is required to monitor foreseeable shortages of therapeutics goods, particularly in regional pharmacies. There is an opportunity for long-term change to retain certain rights and roles based on the competence shown by pharmacists in this challenging period, such as telephone medication reviews, telehealth for MedsCheck and Diabetes MedsCheck, digital prescription handling and therapeutic substitution. Published by Elsevier Inc. 2022-08 2021-08-30 /pmc/articles/PMC8404372/ /pubmed/34810136 http://dx.doi.org/10.1016/j.sapharm.2021.08.013 Text en © 2021 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Parajuli, Daya Ram
Khanal, Saval
Wechkunanukul, Kannikar Hannah
Ghimire, Saurav
Poudel, Arjun
Pharmacy practice in emergency response during the COVID-19 pandemic: Lessons from Australia
title Pharmacy practice in emergency response during the COVID-19 pandemic: Lessons from Australia
title_full Pharmacy practice in emergency response during the COVID-19 pandemic: Lessons from Australia
title_fullStr Pharmacy practice in emergency response during the COVID-19 pandemic: Lessons from Australia
title_full_unstemmed Pharmacy practice in emergency response during the COVID-19 pandemic: Lessons from Australia
title_short Pharmacy practice in emergency response during the COVID-19 pandemic: Lessons from Australia
title_sort pharmacy practice in emergency response during the covid-19 pandemic: lessons from australia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404372/
https://www.ncbi.nlm.nih.gov/pubmed/34810136
http://dx.doi.org/10.1016/j.sapharm.2021.08.013
work_keys_str_mv AT parajulidayaram pharmacypracticeinemergencyresponseduringthecovid19pandemiclessonsfromaustralia
AT khanalsaval pharmacypracticeinemergencyresponseduringthecovid19pandemiclessonsfromaustralia
AT wechkunanukulkannikarhannah pharmacypracticeinemergencyresponseduringthecovid19pandemiclessonsfromaustralia
AT ghimiresaurav pharmacypracticeinemergencyresponseduringthecovid19pandemiclessonsfromaustralia
AT poudelarjun pharmacypracticeinemergencyresponseduringthecovid19pandemiclessonsfromaustralia